These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38236528)

  • 21. Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence.
    Hamilton MJ
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):469-481. PubMed ID: 30007464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for mast cell activation during exercise-induced bronchoconstriction.
    O'Sullivan S; Roquet A; Dahlén B; Larsen F; Eklund A; Kumlin M; O'Byrne PM; Dahlén SE
    Eur Respir J; 1998 Aug; 12(2):345-50. PubMed ID: 9727783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased leukotriene E4 excretion in systemic mastocytosis.
    Butterfield JH
    Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):73-6. PubMed ID: 20380889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis.
    Lueke AJ; Meeusen JW; Donato LJ; Gray AV; Butterfield JH; Saenger AK
    Clin Biochem; 2016 Sep; 49(13-14):979-82. PubMed ID: 26908217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release.
    Stellato C; de Crescenzo G; Patella V; Mastronardi P; Mazzarella B; Marone G
    J Allergy Clin Immunol; 1996 Mar; 97(3):838-50. PubMed ID: 8613641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A US-Based Multicenter Retrospective Report of Perioperative Anaphylaxis, 2010-2021.
    Gonzalez-Estrada A; Carrillo-Martin I; Morgenstern-Kaplan D; Rukasin CRF; Rank MA; Park MA; Yee CI; Volcheck GW
    J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1594-1602.e9. PubMed ID: 38580206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.
    Valent P; Bonadonna P; Hartmann K; Broesby-Olsen S; Brockow K; Butterfield JH; Triggiani M; Lyons JJ; Oude Elberink JNG; Arock M; Metcalfe DD; Akin C
    Int Arch Allergy Immunol; 2019; 180(1):44-51. PubMed ID: 31256161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Approach to Mast Cell Activation Syndrome: A Practical Overview.
    Matito A; Escribese MM; Longo N; Mayorga C; Luengo-Sánchez O; Pérez-Gordo M; Matheu V; Labrador-Horrillo M; Pascal M; Seoane-Reula ME;
    J Investig Allergol Clin Immunol; 2021 Dec; 31(6):461-470. PubMed ID: 33541851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?
    Valent P; Akin C; Arock M
    Curr Allergy Asthma Rep; 2024 Mar; 24(3):133-141. PubMed ID: 38308674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mast cell activation syndrome and the link with long COVID.
    Arun S; Storan A; Myers B
    Br J Hosp Med (Lond); 2022 Jul; 83(7):1-10. PubMed ID: 35938771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increases in urinary 9alpha,11beta-prostaglandin f2 indicate mast cell activation in wine-induced asthma.
    Misso NL; Aggarwal S; Thompson PJ; Vally H
    Int Arch Allergy Immunol; 2009; 149(2):127-32. PubMed ID: 19127069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukotriene E
    Lazarinis N; Bood J; Gomez C; Kolmert J; Lantz AS; Gyllfors P; Davis A; Wheelock CE; Dahlén SE; Dahlén B
    J Allergy Clin Immunol; 2018 Oct; 142(4):1080-1089. PubMed ID: 29518425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation.
    He S; Walls AF
    Eur J Pharmacol; 1997 Jun; 328(1):89-97. PubMed ID: 9203574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs.
    Marone G; Stellato C; Mastronardi P; Mazzarella B
    Ann Fr Anesth Reanim; 1993; 12(2):116-25. PubMed ID: 7690200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation.
    Parente R; Giudice V; Cardamone C; Serio B; Selleri C; Triggiani M
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult-onset mast cell activation syndrome following scombroid poisoning: a case report and review of the literature.
    Brock I; Eng N; Maitland A
    J Med Case Rep; 2021 Dec; 15(1):620. PubMed ID: 34920756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
    Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
    Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus.
    Johnson PR; Ammit AJ; Carlin SM; Armour CL; Caughey GH; Black JL
    Eur Respir J; 1997 Jan; 10(1):38-43. PubMed ID: 9032489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cell activation: beyond histamine and tryptase.
    Theoharides TC; Perlman AI; Twahir A; Kempuraj D
    Expert Rev Clin Immunol; 2023 Jun; 19(6):639-654. PubMed ID: 37029958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors.
    He S; Gaça MD; Walls AF
    Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.